Extranodal Lymphoplasmacytic Lymphoma Responding Rapidly to Zanubrutinib: A Case Series.
Management of recurrent or atypical lymphoplasmacytic lymphoma poses a significant therapeutic challenge.
APA
Brown S, Rusbridge J, et al. (2026). Extranodal Lymphoplasmacytic Lymphoma Responding Rapidly to Zanubrutinib: A Case Series.. Clinical case reports, 14(1), e71756. https://doi.org/10.1002/ccr3.71756
MLA
Brown S, et al.. "Extranodal Lymphoplasmacytic Lymphoma Responding Rapidly to Zanubrutinib: A Case Series.." Clinical case reports, vol. 14, no. 1, 2026, pp. e71756.
PMID
41487988
Abstract
Management of recurrent or atypical lymphoplasmacytic lymphoma poses a significant therapeutic challenge. Here we demonstrate a case series of three patients with atypical presentations of extranodal lymphoplasmacytic lymphoma that each show remarkable and timely responses to Zanubrutinib with a limited side effect profile.
같은 제1저자의 인용 많은 논문 (5)
- Clinical Applications of Tranexamic Acid in Plastic and Reconstructive Surgery.
- Immediate Lymphatic Reconstruction (ILR) for the Prevention of Lymphedema: A Meta-analysis of Prospective Clinical Trials.
- Discussion: The Influence of the Pitanguy Ligament on the Supratip Break Point in Open Rhinoplasty.
- The Vicious Circle of Stasis, Inflammation, and Fibrosis in Lymphedema.
- Beveled Incisions: What is the Evidence?